- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.87 Å
- Oligo State
- homo-dimer
- Ligands
- 6 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN.4: 9 residues within 4Å:- Chain A: S.588, S.591, A.592, N.595, Q.697
- Chain B: H.69, E.233, Y.234, R.311
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:E.233, B:R.311, B:R.311
- Water bridges: B:H.69
NAG-NAG-BMA-MAN.16: 9 residues within 4Å:- Chain A: H.69, E.233, Y.234, R.311
- Chain B: S.588, S.591, A.592, N.595, Q.697
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:E.233, A:R.311, A:R.311
- Water bridges: A:H.69
- 6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.5: 4 residues within 4Å:- Chain A: N.78, T.80, H.81, T.306
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:T.306
- Hydrogen bonds: A:T.80
NAG.6: 2 residues within 4Å:- Chain A: N.152, S.154
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:S.154
NAG.7: 4 residues within 4Å:- Chain A: W.203, N.416, F.522, Y.523
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:W.203, A:Y.523
- Hydrogen bonds: A:W.203, A:F.522
- Water bridges: A:N.416
NAG.17: 4 residues within 4Å:- Chain B: N.78, T.80, H.81, T.306
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:T.306
- Hydrogen bonds: B:T.80
NAG.18: 2 residues within 4Å:- Chain B: N.152, S.154
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:S.154
NAG.19: 4 residues within 4Å:- Chain B: W.203, N.416, F.522, Y.523
5 PLIP interactions:5 interactions with chain B- Hydrophobic interactions: B:W.203, B:Y.523
- Hydrogen bonds: B:W.203, B:F.522
- Water bridges: B:N.416
- 4 x ZN: ZINC ION(Non-covalent)
ZN.8: 6 residues within 4Å:- Chain A: D.344, E.382, Y.509, H.510
- Ligands: ZN.9, 2G5.12
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:D.344, A:E.382, A:E.382, A:H.510
ZN.9: 7 residues within 4Å:- Chain A: H.334, D.344, E.381, E.382, D.410
- Ligands: ZN.8, 2G5.12
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:H.334, A:D.344, A:D.410, A:D.410
ZN.20: 6 residues within 4Å:- Chain B: D.344, E.382, Y.509, H.510
- Ligands: ZN.21, 2G5.24
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:D.344, B:E.382, B:E.382, B:H.510
ZN.21: 7 residues within 4Å:- Chain B: H.334, D.344, E.381, E.382, D.410
- Ligands: ZN.20, 2G5.24
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:H.334, B:D.344, B:D.410, B:D.410
- 2 x CA: CALCIUM ION(Non-covalent)
CA.10: 4 residues within 4Å:- Chain A: T.226, Y.229, E.390, E.393
5 PLIP interactions:5 interactions with chain A- Metal complexes: A:T.226, A:Y.229, A:E.390, A:E.390, A:E.393
CA.22: 4 residues within 4Å:- Chain B: T.226, Y.229, E.390, E.393
5 PLIP interactions:5 interactions with chain B- Metal complexes: B:T.226, B:Y.229, B:E.390, B:E.390, B:E.393
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 2 x 2G5: N-[(S)-[(2S)-2-(benzoylamino)-2-carboxyethoxy](hydroxy)phosphoryl]-L-glutamic acid(Non-covalent)
2G5.12: 20 residues within 4Å:- Chain A: R.167, N.214, H.334, D.344, E.381, E.382, G.384, L.385, D.410, R.420, G.475, N.476, R.491, R.493, Y.509, H.510, K.656, Y.657
- Ligands: ZN.8, ZN.9
21 PLIP interactions:21 interactions with chain A- Hydrophobic interactions: A:L.385, A:Y.657, A:Y.657, A:Y.657
- Hydrogen bonds: A:N.214, A:R.420, A:G.475, A:N.476, A:R.491, A:R.491, A:Y.509
- Water bridges: A:S.411, A:G.475, A:R.493, A:K.656, A:Y.657
- Salt bridges: A:R.167, A:R.491, A:R.493, A:H.510, A:K.656
2G5.24: 20 residues within 4Å:- Chain B: R.167, N.214, H.334, D.344, E.381, E.382, G.384, L.385, D.410, R.420, G.475, N.476, R.491, R.493, Y.509, H.510, K.656, Y.657
- Ligands: ZN.20, ZN.21
22 PLIP interactions:22 interactions with chain B- Hydrophobic interactions: B:L.385, B:Y.657, B:Y.657, B:Y.657
- Hydrogen bonds: B:N.214, B:D.344, B:R.420, B:G.475, B:N.476, B:R.491, B:R.491, B:Y.509
- Water bridges: B:S.411, B:G.475, B:R.493, B:K.656, B:Y.657
- Salt bridges: B:R.167, B:R.491, B:R.493, B:H.510, B:K.656
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Novakova, Z. et al., Design of composite inhibitors targeting glutamate carboxypeptidase II: the importance of effector functionalities. Febs J. (2016)
- Release Date
- 2015-05-20
- Peptides
- Glutamate carboxypeptidase 2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.87 Å
- Oligo State
- homo-dimer
- Ligands
- 6 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x ZN: ZINC ION(Non-covalent)
- 2 x CA: CALCIUM ION(Non-covalent)
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 2 x 2G5: N-[(S)-[(2S)-2-(benzoylamino)-2-carboxyethoxy](hydroxy)phosphoryl]-L-glutamic acid(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Novakova, Z. et al., Design of composite inhibitors targeting glutamate carboxypeptidase II: the importance of effector functionalities. Febs J. (2016)
- Release Date
- 2015-05-20
- Peptides
- Glutamate carboxypeptidase 2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A